Nalotimagene carmaleucel

DB19155InvestigationalCell transplant therapies

Nalotimagene carmaleucel: Overview.

Mechanism: Pharmacologically active on Thymidine kinase
Curator reviewed
Also known as: HSV-TK · human culture expanded activated allogeneic T cells for adjunctive immunotherapy. Cells are derived from the haematopoietic stem cell (HSC) donor and are genetically modified ex vivo with a non-replicative SFCMM-3 gamma- retroviral vector derived from Mo

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nalotimagene carmaleucel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.